Variant report
Variant | nsv945275 |
---|---|
Chromosome Location | chr1:211031192-211034638 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000205339 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188800262 | chr1:211031193-211031194 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs181651332 | chr1:211031223-211031224 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs184621340 | chr1:211031249-211031250 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560431598 | chr1:211031272-211031273 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs527475820 | chr1:211031292-211031293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs190562420 | chr1:211031293-211031294 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs180844775 | chr1:211031294-211031295 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531401142 | chr1:211031323-211031324 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs572507581 | chr1:211031375-211031376 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs142436805 | chr1:211031420-211031421 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs185785346 | chr1:211031482-211031483 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533021184 | chr1:211031503-211031504 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs529589639 | chr1:211031528-211031529 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs546421880 | chr1:211031586-211031587 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs146471542 | chr1:211031601-211031602 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs191033545 | chr1:211031603-211031604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs191185223 | chr1:211031636-211031637 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372839745 | chr1:211031661-211031662 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs28437057 | chr1:211031669-211031670 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs570063051 | chr1:211031699-211031700 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs537508361 | chr1:211031724-211031725 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs181170887 | chr1:211031770-211031771 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs4951668 | chr1:211031776-211031777 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs564911935 | chr1:211031804-211031805 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112742345 | chr1:211031830-211031831 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs369491813 | chr1:211031850-211031851 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184815671 | chr1:211031889-211031890 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs542177063 | chr1:211031902-211031903 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs35843728 | chr1:211031909-211031910 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs554084673 | chr1:211031910-211031911 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs148869676 | chr1:211031917-211031918 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs185769883 | chr1:211031935-211031936 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs190585404 | chr1:211031939-211031940 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369702401 | chr1:211032001-211032002 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs531307840 | chr1:211032010-211032011 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532402972 | chr1:211032025-211032026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs543109853 | chr1:211032037-211032038 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs375391515 | chr1:211032039-211032040 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561386138 | chr1:211032098-211032099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs528837711 | chr1:211032105-211032106 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546960242 | chr1:211032143-211032144 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs559812210 | chr1:211032155-211032156 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs4245747 | chr1:211032194-211032195 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs551688666 | chr1:211032341-211032342 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs570229966 | chr1:211032354-211032355 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs537192670 | chr1:211032375-211032376 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs4504958 | chr1:211032390-211032391 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs551731520 | chr1:211032391-211032392 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs373048563 | chr1:211032401-211032402 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs535035922 | chr1:211032428-211032429 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Macular degeneration | 22558131 | CNVD |
Alzheimer''s disease | 21403675 | CNVD |
Multiple myeloma | 16461302 | CNVD |
van der Woude syndrome | 22470819 | CNVD |
van der Woude syndrome | 20818247 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 17060936 | CNVD |
Atypical hemolytic uremic syndrome | 19861685 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:211024800-211035400 | Weak transcription | HSMM | muscle |
2 | chr1:211024800-211046800 | Weak transcription | HSMMtube | muscle |
3 | chr1:211027000-211035400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr1:211029800-211032600 | Enhancers | Brain Cingulate Gyrus | brain |
5 | chr1:211030400-211031200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
6 | chr1:211030400-211031400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr1:211030400-211031400 | Enhancers | Brain Anterior Caudate | brain |
8 | chr1:211030400-211031600 | Enhancers | Brain Hippocampus Middle | brain |
9 | chr1:211030400-211031800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr1:211030400-211032000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr1:211030600-211031400 | Enhancers | Brain Substantia Nigra | brain |
12 | chr1:211030600-211032000 | Enhancers | Brain Angular Gyrus | brain |
13 | chr1:211030800-211031400 | Enhancers | Brain Inferior Temporal Lobe | brain |
14 | chr1:211031000-211031400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
15 | chr1:211031000-211031400 | Enhancers | A549 | lung |
16 | chr1:211031400-211035400 | Weak transcription | Brain Anterior Caudate | brain |
17 | chr1:211032000-211033000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
18 | chr1:211033000-211034200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
19 | chr1:211033200-211033600 | Enhancers | Placenta | Placenta |